Press Releases April 27, 2026 04:15 PM

Enovix to Report First Quarter 2026 Financial Results on May 13, 2026

Enovix to Announce Q1 2026 Financial Results and Host Earnings Call on May 13, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
ENVX

Enovix Corporation, a Silicon Valley-based developer and manufacturer of advanced lithium-ion batteries, announced it will report its first quarter 2026 financial results on May 13, 2026, after market close. The company will host a live video call to discuss financial results, business updates, commercialization progress, and operational milestones.

Enovix to Report First Quarter 2026 Financial Results on May 13, 2026
ENVX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Enovix focuses on advanced lithium-ion batteries with proprietary silicon-anode technology enhancing energy density and performance in compact devices.
  • The upcoming earnings call on May 13, 2026, will provide insights into the company's recent business and operational progress.
  • Enovix serves a global customer base including consumer electronics, defense, industrial, and emerging edge-AI sectors, with facilities in multiple countries.

FREMONT, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, today announced it will report financial results for the first quarter on Wednesday, May 13, 2026, after the close of the market.

Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on May 13, 2026, to discuss the company’s recent business updates, commercialization progress, operational milestones, and financial results. To join the call, participants must use the following link to register: https://enovix-q1-2026.open-exchange.net/ This link will also be available via the Investor Relations section of Enovix’s website at https://ir.enovix.com. Investors may submit questions on the registration page that they would like addressed on the call by Enovix management.

About Enovix

Enovix develops and manufactures advanced lithium-ion batteries, including proprietary silicon-anode architectures for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications. Its proprietary silicon-anode battery architecture enables higher energy density and performance in space-constrained devices while maintaining safety and reliability, supporting commercialization across consumer and industrial markets.

Enovix is headquartered in Silicon Valley with facilities in India, Korea and Malaysia, servicing customers globally. For more information visit https://enovix.com and follow us on LinkedIn.

Investor Contact:
Robert Lahey
[email protected]

Chief Financial Officer:
Ryan Benton
[email protected]


Risks

  • Commercialization challenges and market adoption risks for advanced lithium-ion battery technology could impact financial performance.
  • Operational risks including supply chain disruptions in international manufacturing locations (India, Korea, Malaysia) may affect production and delivery.
  • Competitive pressures in the battery technology and energy storage sectors could influence market share and profitability.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026